Neurocrine Biosciences Long-Term Investments 2010-2024 | NBIX

Neurocrine Biosciences long-term investments for the quarter ending September 30, 2024 were $0.771B, a 31.17% increase year-over-year.

  • Neurocrine Biosciences long-term investments for 2023 were $0.849B, a 111.56% increase from 2022.
  • Neurocrine Biosciences long-term investments for 2022 were $0.402B, a 35.7% decline from 2021.
  • Neurocrine Biosciences long-term investments for 2021 were $0.624B, a 135.36% increase from 2020.

Neurocrine Biosciences Long-Term Investments 2010-2024 | NBIX

  • Neurocrine Biosciences long-term investments for 2023 were $0.849B, a 111.56% increase from 2022.
  • Neurocrine Biosciences long-term investments for 2022 were $0.402B, a 35.7% decline from 2021.
  • Neurocrine Biosciences long-term investments for 2021 were $0.624B, a 135.36% increase from 2020.